by Evan Sweeney |
Oct 23, 2017 12:16pm
The Association for Behavioral Health and
Wellness (ABHW) called for the president’s opioid commission to consider
nuanced changes to prescription drug monitoring programs and improved access to
telehealth services to adequately address the opioid crisis.
ABHW President and CEO Pamela Greenberg testified on Friday before the
President’s Commission on Combating Drug Addiction and the Opioid Crisis,
highlighting efforts made by the organization’s members to use data analytics
to identify patterns of potential misuse and track prescribing patterns.
Greenberg also outlined several
recommendations to the commission, which is scheduled to release its final
report on November 1. One of those recommendations included allowing Medicaid
managed care organizations, private health plans and pharmacy benefit managers
to access PDMP data to identify members seeking opioids from multiple
providers.
“With access to PDMPs, payers can improve
clinical decision making and patient health care and safety; they can also
become a strategic partner in preventing and identifying abuse,” Greenberg said
in her written testimony (PDF).
She added that PDMP databases should include
methadone prescriptions, which is currently categorized as a medical benefit
rather than a prescription drug benefit.
In draft recommendations issued in August, the
commission, led by New Jersey Gov. Chris Christie, called for enhanced data
sharing between state a federal PDMPs.
Telehealth is another underutilized pathway
for opioid abuse treatment given the shortage of behavioral health providers,
according to Greenberg. She recommended changing the Ryan Haight Online
Pharmacy Consumer Protection Act, which prohibits selling controlled substances
over the internet, to eliminate the requirement for a face-to-face encounter
before behavioral health providers can engage in a telehealth visit. She also
called on Medicare to remove originating site and geographic restrictions to allow
broader access to virtual care.
Some of those telemedicine restrictions would
be addressed if President Donald Trump formally declares the opioid crisis a
national emergency. On Friday, Trump told reporters at the Rose Garden the
White House would issue the declaration this week, more than two months
after making an informal pronouncement.
According to the Department of Health
and Human Services, a public emergency would allow the HHS Secretary and the
Drug Enforcement Agency to make modifications to telehealth laws, including the
Ryan Haight Act.
No comments:
Post a Comment